Amadio, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 396
EU - Europa 310
AS - Asia 130
SA - Sud America 11
AF - Africa 5
Totale 852
Nazione #
US - Stati Uniti d'America 392
DE - Germania 56
SG - Singapore 55
SE - Svezia 54
PL - Polonia 53
CN - Cina 45
IT - Italia 42
FR - Francia 24
UA - Ucraina 18
GB - Regno Unito 14
IE - Irlanda 14
RU - Federazione Russa 11
BE - Belgio 10
ID - Indonesia 10
BR - Brasile 8
FI - Finlandia 8
IN - India 8
TR - Turchia 7
CA - Canada 4
MA - Marocco 3
VN - Vietnam 3
NG - Nigeria 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
IS - Islanda 1
JP - Giappone 1
LV - Lettonia 1
MD - Moldavia 1
MT - Malta 1
PE - Perù 1
VE - Venezuela 1
Totale 852
Città #
Chandler 81
Warsaw 53
Ann Arbor 42
Singapore 27
Ashburn 26
Cattolica 23
Jacksonville 21
Fairfield 18
New York 18
Wilmington 17
Dublin 14
Houston 12
Brussels 10
Jakarta 10
Nanjing 10
San Mateo 10
Bremen 9
Moscow 9
Woodbridge 9
Cambridge 8
Dearborn 8
Izmir 7
Seattle 7
Boston 6
Marseille 6
Boardman 5
Lawrence 5
Hefei 4
Milan 4
Princeton 4
Shenyang 4
The Dalles 4
Dong Ket 3
Frankfurt am Main 3
Toronto 3
Augusta 2
Beijing 2
Falls Church 2
Hebei 2
Katsina 2
Kunming 2
Nanchang 2
Nuremberg 2
Oujda 2
Redmond 2
Rome 2
Tianjin 2
University Park 2
Abu Dhabi 1
Acton 1
Anaco 1
Andover 1
Baton Rouge 1
Cachoeiras de Macacu 1
Changsha 1
Chapel Hill 1
Chicago 1
Chisinau 1
Chiswick 1
Dunoon 1
Düsseldorf 1
Edinburgh 1
Ferrara 1
Fuzhou 1
Genova 1
Guangzhou 1
Helsinki 1
Jinan 1
Lancaster 1
Leawood 1
Lima 1
Montes Claros 1
Morretes 1
Mountain View 1
Nutley 1
Nürnberg 1
Ottawa 1
Paris 1
Phoenix 1
Portsmouth 1
Pune 1
Rabat 1
Redwood City 1
Reykjavik 1
Riga 1
San Diego 1
Santiago 1
Santo Ângelo 1
Shanghai 1
Shenzhen 1
Simi Valley 1
St Helens 1
Stockholm 1
São João de Meriti 1
Taboão da Serra 1
Vila Velha 1
Zhengzhou 1
Totale 575
Nome #
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence 264
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial 92
Impact of bevacizumab containing first line chemotherapy on recurrent disease in epithelial ovarian cancer: A case-control study 88
Targeting the hallmarks of ovarian cancer: The big picture 84
Real-world management of trabectedin/pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian cancer patients: A national survey 75
Emerging drugs for endometrial cancer 74
Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment 72
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 64
Controversy in treatment of advanced ovarian cancer 56
Totale 869
Categoria #
all - tutte 3.631
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.631


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 0 0 0 0 0 0 0 0 0 0 16 12
2020/202186 6 10 3 6 21 4 5 3 8 4 13 3
2021/2022109 17 3 0 7 6 6 0 24 2 9 22 13
2022/2023203 21 30 13 37 18 33 6 14 26 2 3 0
2023/202489 5 23 3 3 2 19 3 7 0 2 9 13
2024/2025102 6 1 14 1 16 4 4 3 33 14 6 0
Totale 869